Fully 70% of patients with nonactive secondary progressive multiple sclerosis (SPMS) who received foralumab nasal spray in an expanded access program (EAP) experienced a lessening in fatigue levels after six months of treatment.
Foralumab found to ease fatigue in SPMS ... - My MSAA Community
Foralumab found to ease fatigue in SPMS patients in access program
Written by
BettysMom
To view profiles and participate in discussions please or .
4 Replies
•
I don't have SPMS, but the concept of a DMT that reduces fatigue in a nasal spray is pretty interesting. Thanks.
that would be awesome. That’s pretty much where my MS is. I haven’t had a flare up in years, just trying to maintain the status quo. Fatigue is one of my biggest symptoms.
Good to see work on a drug for non relapsing SPMS.
Thanks for the information
Not what you're looking for?
You may also like...
Transcranial stimulation reduced fatigue in MS patients
something about this...
Blood Test for MS Activity Gets FDA Breakthrough Designation
relapsing-remitting multiple sclerosis (RRMS) or secondary progressive multiple sclerosis (SPMS),...
Introducing MS self to you
now the lesions in the brain I'm now labeled with SPMS. I went about 25 years not really thinking...
Cost of Continuing Care Communities
over the past several years while on my SSDI for my SPMS.
But, unfortunately, I can't see how I...
Anyone with SPMS on Ocrevus?
if I choose but upon discussion of its effects in SPMS, she did not paint a rosy picture of its...